Escitalopram
31-08-256
Phase 3 small_molecule terminated
Quick answer
Escitalopram for Major Depressive Disorder (MDD) is a Phase 3 program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Beijing Research Institute
- Indication
- Major Depressive Disorder (MDD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated